UPDATE: Exelixis to Acquire Genomica for its Cash | GenomeWeb
Home » UPDATE: Exelixis to Acquire Genomica for its Cash

UPDATE: Exelixis to Acquire Genomica for its Cash

Nov 19, 2001

SAN FRANCISCO, Nov. 19 - Exelixis has agreed to acquire Genomica for a stock-for-stock transaction valued at $110 million, the companies announced on Monday.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Articles

Dec 31, 2015

NeoGenomics Completes Clarient Acquisition

Oct 21, 2015

NeoGenomics to Acquire Clarient From GE

Jul 15, 2016

Sygnis Grosses €5.3M in Rights Offering, Private Placement

Nov 02, 2015

Agilent Completes Seahorse Bio Acquisition

Jan 11, 2016

Foundation Medicine Expects Sharp Rise in Q4, FY2015 Revenues

Apr 29, 2016

People in the News: Michael Ehlers, Ardy Arianpour, and Kimberly Martin

The Scan

This Week in Nature

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Some Cold Water

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA-Based Wanted Sketch

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

So, What's This Exactly?

Researchers discuss the need for antibody standards at a meeting, NPR reports.

Sponsorships

Privacy Policy.  Copyright © 2016 Genomeweb LLC.  All Rights Reserved.